Chairman of Zydus Lifesciences, Pankaj Patel, on Sunday expressed his gratitude upon being bestowed with the Padma Bhushan ...

Innovation from India will bring critical access to affordable healthcare and empower people to lead healthier and more ...

Zydus Lifesciences Chairman Pankaj R Patel awarded Padma Bhushan for contributions to healthcare innovation. Patel emphasizes ...

Zydus Lifesciences Chairman Pankaj R Patel has been awarded the prestigious Padma Bhushan for his contributions to the ...

Zydus, a leading, discovery-based, global pharmaceutical company announced that the US FDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of ...

Zydus has announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of amyotrophic lateral sclerosis (ALS). The designation ...

Ahmedabad: Pankaj R. Patel, the Chairman of Zydus Lifesciences Limited, has been conferred with the Padma Bhushan by the Government of India.Expressing his gratitude on being bestowed with one ...

The US Food and Drug Administration (FDA) has granted approval for Zydus Lifesciences to proceed with a randomised Phase IIb trial of its oral NLRP3 inflammasome inhibitor, Usnoflast, for ...